FDA Output
FDA Output, April 2026
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in April 2026. Updated April 16.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Start-Ups
GT Medical: Treating Brain Tumors with Speed and Certainty
An update on a company bringing localized, immediate, and beam-free radiotherapy to brain cancer patients.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Business Strategies
Treating Heart Failure Systemically
Next-gen start-ups treat heart failure tap into physiological mechanisms to help patients. Excerpted from our recent feature article.